Modified coptisine derivatives as an inhibitor against pathogenic , (Black Fungus), Monkeypox, and Marburg virus by molecular docking and molecular dynamics simulation-based drug design approach.

Shopnil Akash, Arafat Hossain, Nobendu Mukerjee, Md Moklesur Rahman Sarker, Mohammad Firoz Khan, Md Jamal Hossain, Mohammad A Rashid, Ajoy Kumer, Arabinda Ghosh, Darwin A León-Figueroa, Joshuan J Barboza, Bijaya Kumar Padhi, Ranjit Sah
Author Information
  1. Shopnil Akash: Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, Bangladesh.
  2. Arafat Hossain: Department of Biochemistry and Molecular Biology, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj, Bangladesh.
  3. Nobendu Mukerjee: Department of Microbiology, West Bengal State University, Kolkata, West Bengal, India.
  4. Md Moklesur Rahman Sarker: Health Med. Science Research Network, Dhaka, Bangladesh.
  5. Mohammad Firoz Khan: Department of Pharmacy, State University of Bangladesh, Dhaka, Bangladesh.
  6. Md Jamal Hossain: Department of Pharmacy, State University of Bangladesh, Dhaka, Bangladesh.
  7. Mohammad A Rashid: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Dhaka, Dhaka, Bangladesh.
  8. Ajoy Kumer: Laboratory of Computational Research for Drug Design and Material Science, Department of Chemistry, European University of Bangladesh, Dhaka, Bangladesh.
  9. Arabinda Ghosh: Microbiology Division, Department of Botany, Gauhati University, Guwahati, Assam, India.
  10. Darwin A León-Figueroa: Facultad de Medicina Humana, Universidad de San Martín de Porres, Chiclayo, Peru.
  11. Joshuan J Barboza: Escuela de Medicina, Universidad Cesar Vallejo, Trujillo, Peru.
  12. Bijaya Kumar Padhi: Department of Community Medicine, School of Public Health, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  13. Ranjit Sah: Institute of Medicine, Tribhuvan University Teaching Hospital, Kathmandu, Nepal.

Abstract

During the second phase of SARS-CoV-2, an unknown fungal infection, identified as black fungus, was transmitted to numerous people among the hospitalized COVID-19 patients and increased the death rate. The black fungus is associated with the Mycolicibacterium smegmatis, Mucor lusitanicus, and Rhizomucor miehei microorganisms. At the same time, other pathogenic diseases, such as the Monkeypox virus and Marburg virus, impacted global health. Policymakers are concerned about these pathogens due to their severe pathogenic capabilities and rapid spread. However, no standard therapies are available to manage and treat those conditions. Since the coptisine has significant antimicrobial, antiviral, and antifungal properties; therefore, the current investigation has been designed by modifying coptisine to identify an effective drug molecule against Black fungus, Monkeypox, and Marburg virus. After designing the derivatives of coptisine, they have been optimized to get a stable molecular structure. These ligands were then subjected to molecular docking study against two vital proteins obtained from black fungal pathogens: Rhizomucor miehei (PDB ID: 4WTP) and Mycolicibacterium smegmatis (PDB ID 7D6X), and proteins found in Monkeypox virus (PDB ID: 4QWO) and Marburg virus (PDB ID 4OR8). Following molecular docking, other computational investigations, such as ADMET, QSAR, drug-likeness, quantum calculation and molecular dynamics, were also performed to determine their potentiality as antifungal and antiviral inhibitors. The docking score reported that they have strong affinities against Black fungus, Monkeypox virus, and Marburg virus. Then, the molecular dynamic simulation was conducted to determine their stability and durability in the physiological system with water at 100 ns, which documented that the mentioned drugs were stable over the simulated time. Thus, our investigation provides a preliminary report that coptisine derivatives are safe and potentially effective against Black fungus, Monkeypox virus, and Marburg virus. Hence, coptisine derivatives may be a prospective candidate for developing drugs against Black fungus, Monkeypox and Marburg viruses.

Keywords

References

  1. Crit Rev Food Sci Nutr. 2022;62(28):7730-7742 [PMID: 34078189]
  2. J Biomol Struct Dyn. 2022;40(21):11264-11273 [PMID: 34315340]
  3. J Cheminform. 2020 May 8;12(1):30 [PMID: 33431014]
  4. Obstet Gynecol. 2012 Dec;120(6):1407-14 [PMID: 23168767]
  5. Comput Biol Chem. 2018 Dec;77:87-96 [PMID: 30245350]
  6. Molecules. 2022 Jun 08;27(12): [PMID: 35744817]
  7. Vet Q. 2022 Dec;42(1):167-171 [PMID: 35993230]
  8. Curr Med Chem. 2009;16(1):21-41 [PMID: 19149561]
  9. RSC Adv. 2021 Sep 22;11(50):31339-31363 [PMID: 35496831]
  10. Beni Suef Univ J Basic Appl Sci. 2021;10(1):47 [PMID: 34458380]
  11. Free Radic Biol Med. 2019 Apr;134:429-444 [PMID: 30703480]
  12. Clin Infect Dis. 2009 Jan 1;48(1):e6-8 [PMID: 19025497]
  13. Virulence. 2022 Dec;13(1):609-633 [PMID: 35363588]
  14. Proc Natl Acad Sci U S A. 2021 Apr 13;118(15): [PMID: 33876763]
  15. Comput Biol Chem. 2018 Apr;73:65-78 [PMID: 29453141]
  16. J Mol Graph Model. 2006 Dec;25(4):481-6 [PMID: 16644253]
  17. Drug Discov Today. 2002 Jan 15;7(2):109-16 [PMID: 11790621]
  18. J Med Virol. 2023 Jan;95(1):e28036 [PMID: 35906185]
  19. Biosci Trends. 2022 Sep 17;16(4):312-316 [PMID: 35908851]
  20. J Med Chem. 2015 May 14;58(9):4066-72 [PMID: 25860834]
  21. Bioinformatics. 2022 Sep 2;38(17):4233-4234 [PMID: 35792827]
  22. EXCLI J. 2021 Nov 25;20:1597-1607 [PMID: 35024017]
  23. Euro Surveill. 2022 Jun;27(22): [PMID: 35656830]
  24. Expert Opin Drug Discov. 2007 Dec;2(12):1567-77 [PMID: 23488901]
  25. Biomed Res Int. 2013;2013:609289 [PMID: 23984386]
  26. PLoS One. 2019 Feb 20;14(2):e0211935 [PMID: 30785927]
  27. Indian J Med Microbiol. 2013 Jan-Mar;31(1):90-1 [PMID: 23508441]
  28. J Virol. 2014 May;88(10):5859-63 [PMID: 24574400]
  29. Ernst Schering Res Found Workshop. 2002;(37):49-67 [PMID: 11975200]
  30. Acta Crystallogr D Biol Crystallogr. 2015 Aug;71(Pt 8):1714-24 [PMID: 26249352]
  31. Int J Mol Sci. 2021 Mar 30;22(7): [PMID: 33808384]
  32. Nucleic Acids Res. 2012 Jan;40(Database issue):D1100-7 [PMID: 21948594]
  33. Curr Top Med Chem. 2009;9(9):771-90 [PMID: 19754394]
  34. Pharmaceuticals (Basel). 2021 Dec 15;14(12): [PMID: 34959708]
  35. J Mol Model. 2010 Feb;16(2):263-77 [PMID: 19590909]
  36. J Med Chem. 2021 Mar 11;64(5):2489-2500 [PMID: 33617246]
  37. Chem Biol Drug Des. 2018 Feb;91(2):380-390 [PMID: 28816025]
  38. Biochem Biophys Res Commun. 2017 Aug 19;490(2):231-238 [PMID: 28606475]
  39. Front Cell Infect Microbiol. 2022 Aug 22;12:929430 [PMID: 36072227]
  40. Geroscience. 2022 Aug;44(4):2095-2103 [PMID: 35726117]

Word Cloud

Created with Highcharts 10.0.0virusmolecularMonkeypoxMarburgfunguscoptisineBlackdockingderivativesPDBblackpathogenicfungalMycolicibacteriumsmegmatisRhizomucormieheitimeantiviralantifungalinvestigationeffectivedrugstableproteinsID:IDQSARdynamicsdeterminedynamicsimulationdrugsFungussecondphaseSARS-CoV-2unknowninfectionidentifiedtransmittednumerouspeopleamonghospitalizedCOVID-19patientsincreaseddeathrateassociatedMucorlusitanicusmicroorganismsdiseasesimpactedglobalhealthPolicymakersconcernedpathogensdueseverecapabilitiesrapidspreadHoweverstandardtherapiesavailablemanagetreatconditionsSincesignificantantimicrobialpropertiesthereforecurrentdesignedmodifyingidentifymoleculedesigningoptimizedgetstructureligandssubjectedstudytwovitalobtainedpathogens:4WTP7D6Xfound4QWO4OR8FollowingcomputationalinvestigationsADMETdrug-likenessquantumcalculationalsoperformedpotentialityinhibitorsscorereportedstrongaffinitiesconductedstabilitydurabilityphysiologicalsystemwater100nsdocumentedmentionedsimulatedThusprovidespreliminaryreportsafepotentiallyHencemayprospectivecandidatedevelopingvirusesModifiedinhibitorsimulation-baseddesignapproachDFTadmet

Similar Articles

Cited By (3)